封面
市場調查報告書
商品編碼
1594963

胚胎著床前基因檢測的全球市場

Preimplantation Genetic Testing

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球胚胎著床前基因檢測市場將達到 15 億美元

2023 年全球胚胎著床前基因檢測市場預計為 7.68 億美元,預計到 2030 年將達到 15 億美元,2023-2030 年分析期間複合年成長率為 9.9%。試劑和消耗品部分是本報告分析的細分市場之一,預計複合年成長率為 10.6%,在分析期末達到 7.941 億美元。分析期間內,設備產業的複合年成長率預計為 8.9%。

美國市場預估為2.125億美元,中國預期複合年成長率為9.3%

預計 2023 年美國胚胎著床前基因檢測市場規模將達 2.125 億美元。中國作為全球第二大經濟體,預計到 2030 年市場規模將達到 2.269 億美元,2023 年至 2030 年分析期間複合年成長率為 9.3%。其他值得注意的區域市場包括日本和加拿大,預計在分析期間複合年成長率分別為 9.3% 和 8.1%。在歐洲,德國的複合年成長率預計約為 8.1%。

全球胚胎著床前基因檢測市場 - 主要趨勢與促進因素總結

對輔助生殖技術不斷成長的需求如何塑造胚胎著床前基因檢測市場?

胚胎著床前基因檢測(PGT)市場正在經歷顯著成長,這主要是由於對體外受精(IVF)等輔助生殖技術(ART)的需求不斷增加。隨著全球不孕率的上升,越來越多的夫婦正在尋求先進的生殖選擇來實現懷孕,導致 PGT 的利用率增加。該測試可以在胚胎著床前對胚胎進行某些遺傳條件的篩檢,從而增加成功懷孕的機會並降低遺傳疾病的風險。將 PGT 納入 IVF 程序已成為標準做法,並極大地影響了接受 ART 的夫婦的決策流程。隨著基因檢測技術的進步,PGT 已發展到可以為多種遺傳疾病提供更準確、更全面的篩檢,包括染色體異常、單基因疾病和非整倍體。

此外,一般人群對基因檢測的認知和接受度不斷提高,也促進了 PGT 市場的成長。有關基因檢測益處的教育宣傳活動和資訊的提供正在幫助準父母就其生殖健康做出明智的決定。這種趨勢在年長的父母中尤其明顯,由於母親年齡較大,他們可能更關心孩子的遺傳健康。越來越多的生育診所提供此類服務也推動了對 PGT 的需求,這使得以前可能不知道我正在做的選擇的夫婦更容易獲得這種服務。隨著消費者對基因檢測信心的增強,胚胎著床前基因檢測的市場也不斷擴大。

技術進步將在胚胎著床前基因檢測的發展中扮演什麼角色?

技術進步透過實現更準確、更有效率的檢測方法,在改變 PGT 格局方面發揮關鍵作用。次世代定序(NGS) 技術的引入徹底改變了基因檢測,使得以更高的準確性和速度同時分析多個基因和染色體成為可能。 NGS有助於全面的胚胎著床前遺傳學診斷(PGD)和胚胎著床前遺傳學篩檢(PGS),使臨床醫生能夠更有效地識別胚胎中的遺傳異常。該技術不僅提高了遺傳異常的檢出率,還減少了測試所需的時間,這對於 IVF 週期中胚胎選擇的時間敏感至關重要。

此外,胚胎培養技術的進步和延時成像技術的發展改善了胚胎評估,使胚胎學家能夠即時監測胚胎髮育。這些創新可以更好地選擇可行的胚胎,從而最佳化成功植入和懷孕的機會。隨著技術的不斷發展,預計 PGT 將擴大與自動化系統整合,從而增強實驗室工作流程並減少人為錯誤。這種整合將進一步簡化基因檢測流程,使其更有效率且可供患者使用。

消費者偏好的改變如何影響胚胎著床前基因檢測市場?

消費者對個人化醫療保健偏好的變化正在對 PGT 服務的需求產生重大影響。隨著遺傳健康意識的增強,個人和夫婦擴大尋求符合其個人健康目標和生殖計劃的選擇。個人化醫療的趨勢正在導致基因檢測的接受度越來越高,消費者將 PGT 不僅視為遺傳疾病的預防措施,而且視為調整生殖選擇的一種手段。這種轉變在千禧世代和 Z 世代消費者中尤其明顯,他們優先考慮健康並積極控制自己的遺傳健康。

此外,計劃生育的願望以及年輕一代延後生育的趨勢也進一步推動了PGT的需求。當個人優先考慮自己的職業和個人成長時,他們經常尋求有助於降低與高齡產婦相關的風險(包括染色體異常)的生殖技術。由於這一趨勢,基因檢測逐漸被接受為不孕症治療的常規部分,許多準父母認為 PGT 是 IVF 過程中的重要步驟。因此,生育診所擴大提供 PGT 作為其服務的標準組成部分,以滿足患者不斷變化的期望。

推動胚胎著床前基因檢測市場成長的因素有哪些?

胚胎著床前基因檢測(PGT)市場的成長受到多種因素的推動,包括基因檢測技術的進步、不孕率的上升以及消費者對基因健康意識的提高。次世代定序(NGS)和其他創新技術的進步極大地提高了PGT的準確性和效率,使其成為許多接受輔助生殖技術的準父母的首選。此外,隨著越來越多的夫妻尋求增加成功懷孕的機會,不孕症的普遍存在和對 ART 解決方案不斷成長的需求擴大了 PGT 的潛在市場。

此外,消費行為向個人化健康方向的改變也促進了 PGT 的日益普及。隨著越來越多人意識到自己的遺傳健康選擇,對符合特定健康目標的客製化的生殖服務的期望也不斷增加。提供這些服務的生育診所的增加進一步促進了 PGT 與標準 IVF 的整合,使更多人更容易獲得這些服務。對基因檢測的監管支持和醫療保健政策的進步也在促進PGT的採用方面發揮著重要作用。這些因素結合起來,為胚胎著床前基因檢測市場創造了強勁的成長環境,使其成為現代生殖保健的關鍵組成部分。

部分

組件(試劑和耗材、設備、軟體和服務)、技術(次世代定序(NGS)、聚合酵素鏈鎖反應(PCR)、螢光原位雜合技術(FISH)、其他技術)、最終用戶(產科)中心和生育中心診所、醫院、診斷實驗室和服務供應商、研究機構和學術機構)

受訪企業範例(總合34 家知名企業)

  • Ariosa Diagnostics
  • Bioarray SL
  • California Pacific Medical Center(CPMC)
  • CombiMatrix
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genea Limited
  • Genesis Genetics
  • Good Start Genetics, Inc.
  • IGENOMIX
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Oxford Gene Technology
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations, LLC
  • Reprogenetics
  • RHS Ltd.
  • Sequenom
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP22620

Global Preimplantation Genetic Testing Market to Reach US$1.5 Billion by 2030

The global market for Preimplantation Genetic Testing estimated at US$768.0 Million in the year 2023, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2023-2030. Reagents & Consumables Component, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$794.1 Million by the end of the analysis period. Growth in the Instruments Component segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$212.5 Million While China is Forecast to Grow at 9.3% CAGR

The Preimplantation Genetic Testing market in the U.S. is estimated at US$212.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$226.9 Million by the year 2030 trailing a CAGR of 9.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.3% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Preimplantation Genetic Testing Market – Key Trends & Drivers Summarized

How Is the Rising Demand for Assisted Reproductive Technologies Shaping the Preimplantation Genetic Testing Market?

The preimplantation genetic testing (PGT) market is undergoing significant growth, largely driven by the increasing demand for assisted reproductive technologies (ART) such as in vitro fertilization (IVF). As infertility rates rise globally, more couples are seeking advanced reproductive options to achieve pregnancy, leading to an uptick in the utilization of PGT. This testing allows for the screening of embryos for specific genetic conditions before implantation, thereby enhancing the chances of a successful pregnancy and reducing the risk of genetic disorders. The integration of PGT into IVF procedures has become a standard practice, significantly influencing the decision-making process for couples undergoing ART. With the advancements in genetic testing technologies, PGT has evolved to offer more accurate and comprehensive screening for a wide range of genetic disorders, including chromosomal abnormalities, single-gene disorders, and aneuploidies.

Moreover, the increasing awareness and acceptance of genetic testing in the general population are contributing to the growth of the PGT market. Educational campaigns and the availability of information regarding the benefits of genetic testing have empowered prospective parents to make informed decisions about their reproductive health. This trend is particularly pronounced among older parents who may be more concerned about the genetic health of their children due to advanced maternal age. The demand for PGT is also fueled by the increasing number of fertility clinics offering these services, making PGT more accessible to couples who may have previously been unaware of their options. As consumer confidence in genetic testing grows, so does the market for preimplantation genetic testing.

What Role Do Technological Advancements Play in the Evolution of Preimplantation Genetic Testing?

Technological advancements are playing a crucial role in transforming the PGT landscape, enabling more precise and efficient testing methods. The introduction of next-generation sequencing (NGS) technologies has revolutionized genetic testing, allowing for the simultaneous analysis of multiple genes and chromosomes with greater accuracy and speed. NGS facilitates comprehensive preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS), enabling clinicians to identify genetic abnormalities in embryos more effectively. This technology not only enhances the detection rates of genetic disorders but also reduces the time required for testing, which is critical in the time-sensitive context of embryo selection during IVF cycles.

Furthermore, advancements in embryo culture techniques and the development of time-lapse imaging technologies have improved embryo assessment, enabling embryologists to monitor embryo development in real time. These innovations allow for better selection of viable embryos, thus optimizing the chances of successful implantation and pregnancy. As the technology continues to evolve, it is anticipated that PGT will become increasingly integrated with automated systems that enhance laboratory workflows and reduce human error. This integration will further streamline the process of genetic testing, making it more efficient and accessible for patients.

How Are Changing Consumer Preferences Influencing the Preimplantation Genetic Testing Market?

Changing consumer preferences towards personalized healthcare are significantly influencing the demand for PGT services. As awareness about genetic health increases, individuals and couples are more inclined to seek options that align with their personal health goals and reproductive plans. The trend towards personalized medicine has led to a greater acceptance of genetic testing, as consumers view PGT not only as a preventive measure against hereditary diseases but also as a means to tailor their reproductive choices. This shift is particularly evident among millennials and Gen Z consumers, who prioritize health and wellness and are proactive about managing their genetic health.

Additionally, the desire for family planning and the growing trend of delayed parenthood among younger generations further drive the demand for PGT. As individuals prioritize career and personal development, they often seek reproductive technologies that can help mitigate the risks associated with advanced maternal age, including chromosomal abnormalities. This trend has led to a growing acceptance of genetic testing as a routine part of the fertility journey, with many prospective parents considering PGT an essential step in the IVF process. As a result, fertility clinics are increasingly offering PGT as a standard component of their services to meet the evolving expectations of their patients.

What Factors Are Driving Growth in the Preimplantation Genetic Testing Market?

The growth in the preimplantation genetic testing (PGT) market is driven by several factors, including advancements in genetic testing technologies, increasing infertility rates, and rising consumer awareness of genetic health. The evolution of next-generation sequencing (NGS) and other innovative technologies has significantly improved the accuracy and efficiency of PGT, making it a preferred choice for many prospective parents undergoing assisted reproductive technologies. Additionally, the growing prevalence of infertility and the demand for ART solutions have expanded the addressable market for PGT, as couples seek to enhance their chances of a successful pregnancy.

Moreover, changing consumer behaviors towards personalized health and wellness are contributing to the increased adoption of PGT. As more individuals become informed about their genetic health options, there is a rising expectation for tailored reproductive services that align with their specific health goals. The integration of PGT into standard IVF practices is further fueled by the increasing number of fertility clinics offering these services, making them more accessible to a broader population. Regulatory support for genetic testing and advancements in healthcare policies also play a significant role in promoting the adoption of PGT. Together, these factors create a robust growth environment for the preimplantation genetic testing market, positioning it as a critical component of modern reproductive health care.

SCOPE OF STUDY:

The report analyzes the Preimplantation Genetic Testing market in terms of US$ Thousand by the following Component; End-Use; Technology, and Geographic Regions/Countries:

Segments:

Component (Reagents & Consumables, Instruments, Software & Services); Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH), Other Technologies); End-Use (Maternity Centers & Fertility Clinics, Hospitals, Diagnostic Labs & Service Providers, Research Laboratories & Academic Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Ariosa Diagnostics
  • Bioarray S.L.
  • California Pacific Medical Center (CPMC)
  • CombiMatrix
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genea Limited
  • Genesis Genetics
  • Good Start Genetics, Inc.
  • IGENOMIX
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Oxford Gene Technology
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations, LLC
  • Reprogenetics
  • RHS Ltd.
  • Sequenom
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Preimplantation Genetic Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Assisted Reproductive Technologies (ART) Drives Adoption of Preimplantation Genetic Testing (PGT)
    • Increasing Awareness of Genetic Disorders Expands the Addressable Market for Preimplantation Genetic Testing
    • Advancements in Next-Generation Sequencing (NGS) Propel Growth in Preimplantation Genetic Testing for Enhanced Accuracy
    • Growing Focus on Improving In Vitro Fertilization (IVF) Success Rates Strengthens the Business Case for Preimplantation Genetic Testing
    • Increasing Incidence of Genetic Disorders and Chromosomal Abnormalities Spurs Demand for PGT in Fertility Treatments
    • Technological Advancements in Embryo Biopsy Techniques Expand Opportunities for Preimplantation Genetic Testing
    • Rising Adoption of Non-Invasive Genetic Testing Methods Drives Innovation in Preimplantation Genetic Testing
    • Growing Trend Toward Delayed Parenthood Expands Demand for Preimplantation Genetic Testing in Older Patients
    • Increasing Focus on Personalized Medicine in Reproductive Health Expands the Use of Preimplantation Genetic Testing
    • Rising Consumer Demand for Family Planning Solutions Propels Growth in Preimplantation Genetic Testing Market
    • Growing Use of Preimplantation Genetic Testing for Gender Selection Creates New Market Opportunities
    • Expanding Use of Preimplantation Genetic Testing in Detecting Single-Gene Disorders Strengthens Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Preimplantation Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Preimplantation Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Research Laboratories & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Maternity Centers & Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Maternity Centers & Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Maternity Centers & Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Next Generation Sequencing (NGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Next Generation Sequencing (NGS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Preimplantation Genetic Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Preimplantation Genetic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Preimplantation Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION